Larvol Delta - The-Allosteric-Antagonist-of-the-Sigma2-ReceptorsElayta-CT1812-as-a-Therapeutic-Candidate-for-Mild-to-Moderate-Alzheimer39s-Disease-A-Scoping-Systematic-Review

Elayta (CT1812) - Cognition Therap

http://www.ncbi.nlm.nih.gov/pubmed/36675950

Jan 22, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next